|
MX2013010911A
(es)
|
2011-03-23 |
2015-03-03 |
Pioneer Hi Bred Int |
Metodos para producir un locus de rasgo transgenico complejo.
|
|
EP2734621B1
(en)
|
2011-07-22 |
2019-09-04 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
KR102405549B1
(ko)
|
2013-03-15 |
2022-06-08 |
더 제너럴 하스피탈 코포레이션 |
Rna-안내 게놈 편집을 위해 특이성을 증가시키기 위한 절단된 안내 rna(tru-grnas)의 이용
|
|
SMT202100516T1
(it)
|
2013-04-16 |
2021-11-12 |
Regeneron Pharma |
Modificazione mirata del genoma di ratto
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
MX363842B
(es)
|
2013-08-22 |
2019-04-05 |
Du Pont |
Métodos para producir modificaciones genéticas en un genoma vegetal sin incorporar un marcador transgénico seleccionable, y composiciones de éstas.
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
BR112016013400B1
(pt)
|
2013-12-11 |
2023-02-14 |
Regeneron Pharmaceuticals, Inc. |
Método in vitro para modificar um genoma em um lócus genômico de interesse em uma célula pluripotente
|
|
US11053481B2
(en)
|
2013-12-12 |
2021-07-06 |
President And Fellows Of Harvard College |
Fusions of Cas9 domains and nucleic acid-editing domains
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
CA2956487A1
(en)
|
2014-09-12 |
2016-03-17 |
E. I. Du Pont De Nemours And Company |
Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use
|
|
AU2015330699B2
(en)
|
2014-10-10 |
2021-12-02 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
GB201418965D0
(enExample)
|
2014-10-24 |
2014-12-10 |
Ospedale San Raffaele And Fond Telethon |
|
|
CA2963820A1
(en)
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
|
LT3250691T
(lt)
|
2015-01-28 |
2023-09-11 |
Caribou Biosciences, Inc. |
Crispr hibridiniai dnr/rnr polinukleotidai ir naudojimo būdai
|
|
CN107567499A
(zh)
|
2015-03-27 |
2018-01-09 |
纳幕尔杜邦公司 |
大豆u6核小rna基因启动子及其在植物小rna基因的组成型表达中的用途
|
|
GB201506509D0
(en)
|
2015-04-16 |
2015-06-03 |
Univ Wageningen |
Nuclease-mediated genome editing
|
|
US11390884B2
(en)
|
2015-05-11 |
2022-07-19 |
Editas Medicine, Inc. |
Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
|
|
CN116334142A
(zh)
|
2015-06-09 |
2023-06-27 |
爱迪塔斯医药公司 |
用于改善移植的crispr/cas相关方法和组合物
|
|
US20160362667A1
(en)
*
|
2015-06-10 |
2016-12-15 |
Caribou Biosciences, Inc. |
CRISPR-Cas Compositions and Methods
|
|
US9790490B2
(en)
*
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
|
AU2016285724A1
(en)
|
2015-06-29 |
2017-11-16 |
Ionis Pharmaceuticals, Inc. |
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
|
|
US11279928B2
(en)
|
2015-06-29 |
2022-03-22 |
Massachusetts Institute Of Technology |
Compositions comprising nucleic acids and methods of using the same
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
WO2017053879A1
(en)
|
2015-09-24 |
2017-03-30 |
Editas Medicine, Inc. |
Use of exonucleases to improve crispr/cas-mediated genome editing
|
|
WO2017070598A1
(en)
|
2015-10-23 |
2017-04-27 |
Caribou Biosciences, Inc. |
Engineered crispr class 2 cross-type nucleic-acid targeting nucleic acids
|
|
IL294014B2
(en)
|
2015-10-23 |
2024-07-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
RU2018117360A
(ru)
*
|
2015-12-04 |
2020-01-09 |
Карибо Биосайенсиз, Инк. |
Сконструированные нуклеиновые кислоты, нацеленные на нуклеиновую кислоту
|
|
BR112018011503A2
(pt)
|
2015-12-07 |
2018-12-04 |
Zymergen Inc |
promotores da corynebacterium glutamicum
|
|
US9988624B2
(en)
|
2015-12-07 |
2018-06-05 |
Zymergen Inc. |
Microbial strain improvement by a HTP genomic engineering platform
|
|
CN109310784B
(zh)
|
2015-12-07 |
2022-08-19 |
阿克生物公司 |
用于制备和使用指导核酸的方法和组合物
|
|
US11208649B2
(en)
|
2015-12-07 |
2021-12-28 |
Zymergen Inc. |
HTP genomic engineering platform
|
|
WO2017136794A1
(en)
|
2016-02-03 |
2017-08-10 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
US9896696B2
(en)
*
|
2016-02-15 |
2018-02-20 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
|
WO2017165826A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
|
WO2017180694A1
(en)
|
2016-04-13 |
2017-10-19 |
Editas Medicine, Inc. |
Cas9 fusion molecules gene editing systems, and methods of use thereof
|
|
US12410416B2
(en)
|
2016-04-19 |
2025-09-09 |
The Broad Institute, Inc. |
CRISPR enzymes and systems with modified pam specificity
|
|
CN106244591A
(zh)
*
|
2016-08-23 |
2016-12-21 |
苏州吉玛基因股份有限公司 |
修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
|
|
EA201892810A1
(ru)
|
2016-06-01 |
2019-06-28 |
Квс Заат Се |
Гибридные последовательности нуклеиновых кислот для геномной инженерии
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
EP3478833A4
(en)
|
2016-06-30 |
2019-10-02 |
Zymergen, Inc. |
METHOD FOR PRODUCING A BACTERIAL HEMOGLOBIN LIBRARY AND ITS USE
|
|
JP2019519241A
(ja)
|
2016-06-30 |
2019-07-11 |
ザイマージェン インコーポレイテッド |
グルコース透過酵素ライブラリーを生成するための方法およびその使用
|
|
US11845929B2
(en)
|
2016-07-08 |
2023-12-19 |
Ohio State Innovation Foundation |
Modified nucleic acids, hybrid guide RNAs, and uses thereof
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
CN109804066A
(zh)
|
2016-08-09 |
2019-05-24 |
哈佛大学的校长及成员们 |
可编程cas9-重组酶融合蛋白及其用途
|
|
US20190264193A1
(en)
|
2016-08-12 |
2019-08-29 |
Caribou Biosciences, Inc. |
Protein engineering methods
|
|
SG11201901306XA
(en)
|
2016-08-19 |
2019-03-28 |
Toolgen Inc |
Artificially engineered angiogenesis regulatory system
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
US11306305B2
(en)
|
2016-09-23 |
2022-04-19 |
Board Of Trustees Of Southern Illinois University |
Tuning CRISPR/Cas9 activity with chemically modified nucleotide substitutions
|
|
EP3523427A4
(en)
|
2016-10-07 |
2020-09-02 |
Integrated DNA Technologies, Inc. |
S. PYOGENES AND POLYPEPTIDES MUTANT CAS9 GENES CODED BY SUCH GENES
|
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
|
CN110214180A
(zh)
|
2016-10-14 |
2019-09-06 |
哈佛大学的校长及成员们 |
核碱基编辑器的aav递送
|
|
US20180282722A1
(en)
*
|
2016-11-21 |
2018-10-04 |
Massachusetts Institute Of Technology |
Chimeric DNA:RNA Guide for High Accuracy Cas9 Genome Editing
|
|
WO2018098383A1
(en)
|
2016-11-22 |
2018-05-31 |
Integrated Dna Technologies, Inc. |
Crispr/cpf1 systems and methods
|
|
US9816093B1
(en)
|
2016-12-06 |
2017-11-14 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
WO2018111947A1
(en)
|
2016-12-12 |
2018-06-21 |
Integrated Dna Technologies, Inc. |
Genome editing enhancement
|
|
EP3555297A1
(en)
|
2016-12-19 |
2019-10-23 |
Editas Medicine, Inc. |
Assessing nuclease cleavage
|
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
|
US20190382751A1
(en)
*
|
2016-12-28 |
2019-12-19 |
Ionis Pharmaceuticals, Inc. |
Modified crispr rna and uses thereof
|
|
WO2018129368A2
(en)
|
2017-01-06 |
2018-07-12 |
Editas Medicine, Inc. |
Methods of assessing nuclease cleavage
|
|
EP3574101B1
(en)
*
|
2017-01-30 |
2023-04-19 |
KWS SAAT SE & Co. KGaA |
Repair template linkage to endonucleases for genome engineering
|
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
WO2018165631A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
KR20240116572A
(ko)
|
2017-03-23 |
2024-07-29 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
|
CA3084252A1
(en)
|
2017-03-28 |
2018-10-04 |
Caribou Biosciences, Inc. |
Crispr-associated (cas) protein
|
|
WO2018201086A1
(en)
|
2017-04-28 |
2018-11-01 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide rna molecules
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
CN108977442B
(zh)
*
|
2017-06-05 |
2023-01-06 |
广州市锐博生物科技有限公司 |
用于dna编辑的系统及其应用
|
|
EP3635113A4
(en)
|
2017-06-05 |
2021-03-17 |
Fred Hutchinson Cancer Research Center |
SAFE GENOMIC HAVERS FOR GENETIC THERAPIES IN HUMAN STEM CELLS AND NANOPARTICLES MODIFIED TO ENABLE TARGETED GENETIC THERAPIES
|
|
JP2020524490A
(ja)
|
2017-06-06 |
2020-08-20 |
ザイマージェン インコーポレイテッド |
Ｅｓｃｈｅｒｉｃｈｉａ Ｃｏｌｉを改良するためのＨＴＰゲノム操作プラットフォーム
|
|
EP3635112A2
(en)
|
2017-06-06 |
2020-04-15 |
Zymergen, Inc. |
A htp genomic engineering platform for improving fungal strains
|
|
EP3635114B1
(en)
*
|
2017-06-07 |
2024-11-06 |
Arc Bio, LLC |
Creation and use of guide nucleic acids
|
|
KR102746733B1
(ko)
|
2017-06-09 |
2024-12-24 |
에디타스 메디신, 인코포레이티드 |
조작된 cas9 뉴클레아제
|
|
US10907150B2
(en)
|
2017-06-14 |
2021-02-02 |
Wisconsin Alumni Research Foundation |
Modified guide RNAs, CRISPR-ribonucleotprotein complexes and methods of use
|
|
WO2019014564A1
(en)
|
2017-07-14 |
2019-01-17 |
Editas Medicine, Inc. |
SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES
|
|
CN112501254B
(zh)
|
2017-07-14 |
2024-07-19 |
上海吐露港生物科技有限公司 |
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
|
|
US11584955B2
(en)
*
|
2017-07-14 |
2023-02-21 |
Shanghai Tolo Biotechnology Company Limited |
Application of Cas protein, method for detecting target nucleic acid molecule and kit
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
EP3665279B1
(en)
|
2017-08-09 |
2023-07-19 |
Benson Hill, Inc. |
Compositions and methods for modifying genomes
|
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
|
WO2019046540A1
(en)
|
2017-08-31 |
2019-03-07 |
New York Genome Center, Inc. |
METHODS AND COMPOSITIONS COMPRISING CRISPR-CPF1 AND APPROVED GUIDING CRISPR RNAES FOR PROGRAMMABLE GENOMIC DELETIONS
|
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
|
WO2019099943A1
(en)
|
2017-11-16 |
2019-05-23 |
Astrazeneca Ab |
Compositions and methods for improving the efficacy of cas9-based knock-in strategies
|
|
WO2019113132A1
(en)
|
2017-12-05 |
2019-06-13 |
Caribou Biosciences, Inc. |
Modified lymphocytes
|
|
EP3724216A1
(en)
|
2017-12-15 |
2020-10-21 |
Dana Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
WO2019147743A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
WO2019152941A1
(en)
|
2018-02-05 |
2019-08-08 |
Caribou Biosciences, Inc. |
Engineered gut microbes for reduction of reactivation of detoxified drugs
|
|
US12084676B2
(en)
|
2018-02-23 |
2024-09-10 |
Pioneer Hi-Bred International, Inc. |
Cas9 orthologs
|
|
WO2019173248A1
(en)
|
2018-03-07 |
2019-09-12 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
JP7555822B2
(ja)
|
2018-04-19 |
2024-09-25 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
ゲノム編集のための組成物および方法
|
|
GB2589246A
(en)
|
2018-05-16 |
2021-05-26 |
Synthego Corp |
Methods and systems for guide RNA design and use
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
US12227776B2
(en)
|
2018-06-13 |
2025-02-18 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
|
CA3102148A1
(en)
*
|
2018-06-13 |
2019-12-19 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
|
US10227576B1
(en)
|
2018-06-13 |
2019-03-12 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
|
US12338436B2
(en)
|
2018-06-29 |
2025-06-24 |
Editas Medicine, Inc. |
Synthetic guide molecules, compositions and methods relating thereto
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
JP7649735B2
(ja)
|
2018-09-07 |
2025-03-21 |
アストラゼネカ・アクチエボラーグ |
改善されたヌクレアーゼのための組成物及び方法
|
|
DK3833682T3
(da)
|
2018-10-01 |
2022-10-03 |
Caribou Biosciences Inc |
Selvmordsmolekyle sammensætninger og fremgangsmåder
|
|
KR102126573B1
(ko)
|
2018-10-18 |
2020-06-26 |
대한민국 |
CRISPR-Cas9 시스템을 이용한 유색고약버섯의 리그닌 분해효소의 유전자 편집방법 및 이의 용도
|
|
US12281338B2
(en)
|
2018-10-29 |
2025-04-22 |
The Broad Institute, Inc. |
Nucleobase editors comprising GeoCas9 and uses thereof
|
|
KR20210088615A
(ko)
*
|
2018-10-31 |
2021-07-14 |
지머젠 인코포레이티드 |
Dna 라이브러리의 다중 결정적 어셈블리
|
|
US11739320B2
(en)
|
2018-11-05 |
2023-08-29 |
Wisconsin Alumni Research Foundation |
Gene correction of Pompe disease and other autosomal recessive disorders via RNA-guided nucleases
|
|
EP3894550A4
(en)
|
2018-12-14 |
2023-01-04 |
Pioneer Hi-Bred International, Inc. |
NOVEL CRISPR-CAS SYSTEMS FOR GENOME EDITING
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
GB2597377A
(en)
*
|
2019-01-25 |
2022-01-26 |
Synthego Corp |
Systems and methods for modulating CRISPR activity
|
|
WO2020176389A1
(en)
|
2019-02-25 |
2020-09-03 |
Caribou Biosciences, Inc. |
Plasmids for gene editing
|
|
KR20210136997A
(ko)
|
2019-03-08 |
2021-11-17 |
지머젠 인코포레이티드 |
미생물에서 반복적 게놈 편집
|
|
US11053515B2
(en)
|
2019-03-08 |
2021-07-06 |
Zymergen Inc. |
Pooled genome editing in microbes
|
|
CA3130488A1
(en)
|
2019-03-19 |
2020-09-24 |
David R. Liu |
Methods and compositions for editing nucleotide sequences
|
|
US10982187B2
(en)
|
2019-03-26 |
2021-04-20 |
Genus Plc |
Bos taurus variety ‘HO840003150607238’ and methods of use thereof
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US10975351B2
(en)
|
2019-06-17 |
2021-04-13 |
Abs Global, Inc. |
Bos taurus variety ‘JE840003146074527’ and methods of use therof
|
|
CA3153301A1
(en)
*
|
2019-09-05 |
2021-03-11 |
Benson Hill, Inc. |
Compositions and methods for modifying genomes
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
US20230002761A1
(en)
|
2019-11-19 |
2023-01-05 |
Benson Hill, Inc. |
Anti-bacterial crispr compositions and methods
|
|
EP4028521A1
(en)
|
2019-12-09 |
2022-07-20 |
Caribou Biosciences, Inc. |
Crispr abasic restricted nucleotides and crispr accuracy via analogs
|
|
CA3166430A1
(en)
*
|
2020-02-05 |
2021-08-12 |
Ryan T. Gill |
Compositions and methods for targeting, editing or modifying human genes
|
|
US20230087228A1
(en)
*
|
2020-02-24 |
2023-03-23 |
The Broad Institute, Inc. |
Novel type iv and type i crispr-cas systems and methods of use thereof
|
|
US20230340538A1
(en)
|
2020-04-08 |
2023-10-26 |
Astrazeneca Ab |
Compositions and methods for improved site-specific modification
|
|
WO2021226558A1
(en)
|
2020-05-08 |
2021-11-11 |
The Broad Institute, Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
CN115956120A
(zh)
*
|
2020-05-12 |
2023-04-11 |
马萨诸塞大学 |
用于crispr基因组编辑的修饰的指导rna
|
|
US20250027078A1
(en)
*
|
2020-10-19 |
2025-01-23 |
Caribou Biosciences, Inc. |
Dna-containing polynucleotides and guides for crispr type v systems, and methods of making and using the same
|
|
CN112301162B
(zh)
*
|
2020-10-22 |
2023-09-22 |
清华-伯克利深圳学院筹备办公室 |
同时检测dna病毒和rna病毒的病毒核酸检测方法
|
|
US20240182890A1
(en)
|
2021-04-07 |
2024-06-06 |
Astrazeneca Ab |
Compositions and methods for site-specific modification
|
|
GB202509407D0
(en)
*
|
2021-09-22 |
2025-07-30 |
Verve Therapeutics Inc |
Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of disease
|
|
EP4408996A2
(en)
|
2021-09-30 |
2024-08-07 |
Astrazeneca AB |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
|
CN117999481A
(zh)
|
2021-10-26 |
2024-05-07 |
卡里布生物科学公司 |
核酸外切酶偶联实时核酸内切酶活性测定
|
|
IL312921A
(en)
*
|
2021-12-07 |
2024-07-01 |
Caribou Biosciences Inc |
A method for capturing CRISPR endonuclease cleavage products
|
|
EP4499829A2
(en)
*
|
2022-03-29 |
2025-02-05 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treatment of transthyretin amyloidosis
|
|
KR20250005083A
(ko)
*
|
2022-04-13 |
2025-01-09 |
카리부 바이오사이언시스 인코포레이티드 |
Crispr v형 시스템의 치료학적 응용
|
|
WO2023224327A1
(ko)
*
|
2022-05-20 |
2023-11-23 |
한국생명공학연구원 |
오토라이신을 활용한 미세조류의 유전자 교정 효율을 증대시키기 위한 시스템 및 방법
|
|
EP4504764A1
(en)
|
2022-05-26 |
2025-02-12 |
Caribou Biosciences, Inc. |
Cytokine-receptor fusions for immune cell stimulation
|
|
WO2023240042A1
(en)
|
2022-06-06 |
2023-12-14 |
Caribou Biosciences, Inc. |
Treatment of autoimmune diseases with engineered immune cells
|
|
EP4578945A4
(en)
|
2022-08-26 |
2025-12-17 |
Guangzhou Reforgene Medicine Co Ltd |
CRISPR-CAS13 SYSTEM AND ITS USE
|
|
IL319598A
(en)
|
2022-09-30 |
2025-05-01 |
Caribou Biosciences Inc |
Anti-ROR1 chimeric antigen receptors, CAR-NK cells and related methods
|
|
EP4584283A1
(en)
|
2022-11-14 |
2025-07-16 |
Caribou Biosciences, Inc. |
Anti-cll-1 chimeric antigen receptors, engineered cells and related methods
|
|
EP4414452A1
(en)
*
|
2023-02-13 |
2024-08-14 |
Universidad de Granada |
Dual-guide rna composition for executing a single-guide rna crispr-associated system
|
|
WO2024201368A1
(en)
|
2023-03-29 |
2024-10-03 |
Astrazeneca Ab |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
|
AU2024265453A1
(en)
|
2023-05-01 |
2025-09-25 |
Caribou Biosciences, Inc. |
Treatment of autoimmune diseases with bcma-targeting engineered immune cells
|
|
AU2024270764A1
(en)
|
2023-05-15 |
2025-12-04 |
Nchroma Bio, Inc. |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
WO2025006880A1
(en)
|
2023-06-29 |
2025-01-02 |
Caribou Biosciences, Inc. |
Diagnostic and therapeutic methods for use with ror1 antagonists
|
|
WO2025024676A1
(en)
|
2023-07-26 |
2025-01-30 |
Caribou Biosciences, Inc. |
In vitro validation methods for cd19-targeting cell therapies
|
|
CN119614679A
(zh)
*
|
2023-09-14 |
2025-03-14 |
厦门大学 |
一款通用型核酸检测平台
|
|
WO2025064930A1
(en)
*
|
2023-09-20 |
2025-03-27 |
Emory University |
Nucleic acid hairpin based triggered hydrogels and uses thereof
|
|
WO2025117745A1
(en)
|
2023-12-01 |
2025-06-05 |
Caribou Biosciences, Inc. |
Methods and compositions for improving precision of endonuclease-mediated genome editing
|
|
WO2025193609A1
(en)
|
2024-03-11 |
2025-09-18 |
Caribou Biosciences, Inc. |
Methods and compositions for cost-effective assessment of nucleic acid transcripts and isoforms in cells
|
|
WO2025193386A1
(en)
|
2024-03-13 |
2025-09-18 |
Caribou Biosciences, Inc. |
Treatment regimens for autoimmune disease with cd19-targeting engineered immune cells
|
|
WO2026024468A1
(en)
|
2024-07-26 |
2026-01-29 |
Caribou Biosciences, Inc. |
Modular linked chimeric antigen receptors
|